Yoshiaki Omura received Oncological Residency training at Cancer Institute of Columbia University & Doctor of Science Degree through research on Pharmaco-Electro-Physiology of Single Cardiac Cells in-vivo and in-vitro from Columbia University. He researched EMF Resonance phenomenon at Graduate Experimental Physics Dept., Columbia University. He published over 270 original research articles, many chapters & 9 books. He is currently Adjunct Prof. of Family & Community Medicine, NY Medical College and Director of Medical Research, Heart Disease Research Foundation of NY. He is the President and Professor of International College of Acupuncture & Electro-Therapeutics, NY. He is the Editor-in-Chief of Acupuncture & Electro-Therapeutics Research, Int’l Journal of Integrative Medicine, (indexed by 17 major int’l Indexing Periodicals). He also serves as an Editor of Integrative Oncology. Formerly, he was also Adjunct Prof. or Visiting Prof. of Universities in USA, France, Italy, Japan, Korea, China, etc.

Single Cardiac Cells, Integrative Oncology, Heart Disease

Professor Hennekens is the first Sir Richard Doll Professor and Senior Academic Advisor to the Dean. He was first John Snow and first Eugene Braunwald Professor of Medicine at Harvard Medical School and first Chief of Preventive Medicine at Brigham and Women’s Hospital. His 173 H-index ranks him #14 Top Scientist in World. He was 3rd most widely cited medical researcher in world and 5 of top 20 were former trainees. He is #81 in world history for saving 1.1 million lives. He is a Fellow of the American College of Preventive Medicine (FACPM) and the American College of Cardiology (FACC).

Introductory and advanced epidemiology, myocardial infarction, stroke and cardiovascular death.

Sweeney obtained his BSc and PhD in Pharmacology at University of Glasgow, UK. He then moved to the Hospital for Sick Children in Toronto as postdoctoral fellow. Dr. Sweeney is now Professor in the Department of Biology at York University. He has also served as Chief Scientific Officer and Diabetes Group Leader at Institut Pasteur Korea, a world-leading translational research institute. His research is funded by Canadian Institutes of Health Research, Canadian Diabetes Association and Heart & Stroke Foundation of Canada. Studies have resulted in publications in leading journals including Diabetes, Nature Reviews Cardiology, Proc Natl Acad Sci USA, Journal of Clinical Endocrinology & Metabolism, Endocrinology and Cell Metabolism. These studies focus mainly on diabetes and cardiovascular disease, in particular the mechanisms linking obesity with diabetes and heart failure.

Obesity, diabetes and heart failure

Costigliola graduated in Medicine from the University of Naples in 1972 and in Anaesthesiology and Intensive Care from the University of Pisa in 1978. He also attended post-graduated studies in Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession. His professional experience ranges from senior military positions as Chief of Medical Services in the Italian Navy for a number of years, responsibility of the outpatients clinic of the Shape Hospital in Belgium and family practice in Italy and Belgium. Costigliola practice in Italian, French, English and Spanish.

Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action

Trudie C. A. Lobban MBE, FRCP (Edin) is Trustee and Founder of Arrhythmia Alliance (A-A). Recognised as a world expert on all forms of arrhythmias, Trudie represents patients and their caregivers, as well as working closely with everyone involved in the care and treatment of those affected by cardiac arrhythmias and sudden cardiac arrest. Established in 2004, the charity was successful in the introduction of a new chapter in the National Service Framework (NSF) for Coronary Heart Disease on Arrhythmias and Sudden Cardiac Death. Trudie was a member of the expert group engaged by the Department of Health to produce the first significant healthcare document specifically addressing arrhythmia services. She is instrumental in the development of A-A National Partners throughout Europe, America and Asia, and spearheaded the first international awareness event, World Heart Rhythm Week, supported by the World Society of Arrhythmias. Trudie has written papers and a chapter on syncope and arrhythmias as well as being a member of several research projects. She was awarded an MBE for her services to healthcare in 2008 and became a FRCP (Edin) in 2014. She is an internationally recognised patient expert and presents globally at scientific congresses.

Coronary Heart Disease, Arrhythmias and Sudden Cardiac Death

Trudie C. A. Lobban MBE, FRCP (Edin) is Trustee and Founder of Arrhythmia Alliance (A-A). Recognised as a world expert on all forms of arrhythmias, Trudie represents patients and their caregivers, as well as working closely with everyone involved in the care and treatment of those affected by cardiac arrhythmias and sudden cardiac arrest. Established in 2004, the charity was successful in the introduction of a new chapter in the National Service Framework (NSF) for Coronary Heart Disease on Arrhythmias and Sudden Cardiac Death. Trudie was a member of the expert group engaged by the Department of Health to produce the first significant healthcare document specifically addressing arrhythmia services. She is instrumental in the development of A-A National Partners throughout Europe, America and Asia, and spearheaded the first international awareness event, World Heart Rhythm Week, supported by the World Society of Arrhythmias. Trudie has written papers and a chapter on syncope and arrhythmias as well as being a member of several research projects. She was awarded an MBE for her services to healthcare in 2008 and became a FRCP (Edin) in 2014. She is an internationally recognised patient expert and presents globally at scientific congresses.

Coronary Heart Disease, Arrhythmias and Sudden Cardiac Death

Giugliano is a Senior Investigator with the TIMI Study Group, Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. He hold degrees from Dartmouth College (1985 A.B. Mathematics, Phi Beta Kappa), Harvard Medical School (1989 MD), and Harvard School of Public Health (1997 Science Masters - Epidemiology). He trained in Internal Medicine at Cedars-Sinai (Los Angeles) and Cardiovascular Medicine at Massachusetts General Hospital (Boston). His areas of research interests include novel antithrombotic and fibrinolytic agents, lipid-lowering therapies, and the assessment of outcomes in patients with ACS.

Novel antithrombotic and fibrinolytic agents, lipid-lowering therapies

S Jamal Mustafa is the Professor of Physiology and Pharmacology at West Virginia University (WVU). He has received Dean’s Award for Excellence in Research from SOM in 2008 and became a Robert C. Byrd Professor in 2010 and received Chancellor’s Award for Outstanding Achievement in Research and Scholarly Activities from HSC, in 2013. He has also published over 200 manuscripts. His past work has led to the approval of an A2A selective AR agonist (Lexican®) for myocardial perfusion imaging. Currently, he is using AR and β adrenergic receptor KOs to better understand the relationship between these receptors in coronary flow regulation.

AR, β adrenergic receptor KOs, myocardial perfusion imaging

Sergey Suchkov was born in Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, Suchkov graduated from Astrakhan State Medical University and awarded with MD. In 1985, Suchkov maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences. In 2001, Suchkov maintained his Doctor ship degree at the National Institute of Immunology, Russia. From 1985 through 1987, Dr Suchkov worked as a Post Doc Res Associate, Dept. of Med Bio-technology, Inst of Med Enzymology and USSR Academy of Medical Sciences to be involved into research in epigenomic methylation. From 1987 through 1989, Dr Suchkov was a senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, Dr Suchkov was being a Head of the Lab of Clinical Immunology and Immunobi-otechnology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, Dr Suchkov was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. Dr Suchkov has been trained at: ● NIH; ● Wills Eye Hospital, PA, USA; ● Univ of Florida in Gainesville; ● UCSF, S-F, CA, USA; ● Center for Autoimmunity Research, Johns Hopkins University, Baltimore, MD, USA as well as at some of the British and Swedish Universities on the invitation of the Royal Society for Immunology and Karolinska Academy, respectively. In 1993-1996, Dr Suchkov was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, M, PhD, is: ● Prof in Immunology, Dept of Pathology, I.M. Sechenov First Moscow State Medical University; ● Dept of Clin Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Dean of the Dept for PPPM Development, and the First Vice-President of the University of World Business, Politics and Law; ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. Dr Suchkov is an author of more than 500 publications including 10 patents and more than 10 monographs, handbooks and textbooks. Dr Suchkov is a member of the: ● New York Academy of Sciences, USA; ● American Chemical Society (ACS), USA; ● American Heart Association (AHA), USA; ● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ● ARVO (American Association for Research in Vision and Ophthalmology); ● ISER (International Society for Eye Research); ● PMC (Personalized Medicine Coalition), Washington, USA; ● All-Union (from 1992 - Russian) Biochemical Society; ● All-Union (from 1992 - Russian) Immunological Society. Dr Suchkov is a member of the Editorial Boards of “Open Journal of Immunology”, “EPMA J.”, “American J. of Cardiovascular Research”, “Jacobs J.Biomarkers” and “Personalized Medicine Universe”.

Microbial antigens, epigenomic methylation, Immunobiotechnology

HK Chopra, a cardiologist working with Moolchand Medcity was elected unanimously as a ‘President of Cardiological Society of India’ at Hyderabad. Chopra said that his mandate in 2015 is to enhance awareness about hypertension, heart attacks and obesity. He also said that he will focus on developing technology in interventional cardiology in India and enhance awareness about timely intake of effective heart protective pill for Indians. He also said that lifestyle optimisation through alliance with governmental and non-governmental organisations and prevention of risk factors will help prevent heart attack in India below the age of 70. He emphasised that ‘Healthy Heart India is Fit India’.

Hypertension, heart attacks and obesity

Eugenio Greco is the Contract Professor of Technical Science and Laboratory; School of Medicine, Study University of Catania, Italy; and the Fellow of the European Society of Cardiology.

Epidemiology

Filio Billia is director of research at Peter Munk Cardiac Centre (PMCC), medical director of the Mechanical Circulatory Support Program, and co-director of the PMCC Cardiovascular Biobank. A Toronto General Research Institute scientist, Dr. Billia leads a team that studies the molecular mechanisms involved in heart failure. She is also assistant professor at the University Toronto’s Department of Medicine.

Heart failure, knockout mice, cardiac regeneration